1. Instructions for medical use of the drug Texared® lyophilisate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
The information is intended for medical and pharmaceutical workers
Know More1. Instructions for medical use of the drug Texared® lyophilisate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
*Acute musculoskeletal disorders usually do not require therapy for more than 7 days, but in severe cases it can be continued, up to a maximum of 14 days. (Instruction for the medical use of the drug Texared® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21).
The information is intended for medical and pharmaceutical workers
Know More15 minutes after intramuscular administration, the concentration of tenoxicam reaches 90% of the maximum possible value [1,2]
1. Instructions for medical use of the drug Texared® lyophilisate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
3. Instructions for medical use of the drug Movalis ® injection RU P N012978/01 dated 31.03.17; Movalis tablets RU P No. N012978/01 dated 05/28/21
The information is intended for medical and pharmaceutical workers
Know More* https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=a0772943-769d-44f5-a48a-c18c936e001a (accessed 06/01/2022)
1. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
The information is intended for medical and pharmaceutical workers
Know More1. Instructions for the medical use of the drug Texared® lyophilizate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for the medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
3. Gonzalez JP, Todd PA. Tenoxicam: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. drugs. 1987; 34:289-310.
4. Tanaka Y, Himori N. Analgesic actions of tenoxicam in various inflammatory animal models. Japanese Pharmacology and Therapeutics. 1988; 16:43-55
5. Drugs Therapy Perspectives, 2000
6. Xu S, Rouzer CA, Marnett LJ. IUBMB Life. Dec 2014; 66(12): 803-811
7. Braga PC, Biella G, Tiengo M. Effects of tenoxicam on nociceptive thalamic neuronal firing in arthritic rats. Drugs under Experimental and Clinical Research. 1987; 13:389-398
8. Instructions for the medical use of the drug Texared® lyophilizate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
9. "Observational study to evaluate the efficacy and safety of tenoxicam in dorsalgia in comparison with meloxicam and diclofenac sodium" Rachin A.P. Breast cancer No. 4 dated 11/27/18
10. Vignon E, Mathieu P, Louisot P, Richard M. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum. 1991 Oct;34(10):1332-5.
11. Ozgocmen S, Ardicoglu O, Erdogan H, Fadillioglu E, Gudul H. In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis. Ann Clinic Lab Sc. 2005;35(2):137-143